Skip to main content

Published locations for ELIXA Trial: No Cardiovascular Risk With GLP-1 Receptor Agonist Lixisenatide

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. ELIXA Trial: No Cardiovascular Risk With GLP-1 Receptor Agonist Lixisenatide

User login

  • Reset your password
  • /content/elixa-trial-no-cardiovascular-risk-glp-1-receptor-agonist-lixisenatide-0
  • /clinicianreviews/article/100442/diabetes/elixa-trial-no-cardiovascular-risk-glp-1-receptor-agonist
  • /type-2-diabetes-icymi/article/100442/diabetes/elixa-trial-no-cardiovascular-risk-glp-1-receptor